Evidence map›Paper›PMID 27980070›Full record

ArticleJournal of cell science2017

Δ40p53α suppresses tumor cell proliferation and induces cellular senescence in hepatocellular carcinoma cells.

Akinobu Ota, Haruhisa Nakao, Yumi Sawada, Sivasundaram Karnan, Md Wahiduzzaman, Tadahisa Inoue, Yuji Kobayashi, Takaya Yamamoto, Norimitsu Ishii, Tomohiko Ohashi and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of cell science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. The p53 Isoforms as Potential Biomarkers in Different Cancer Entities.International journal of molecular sciences · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. A Novel Mechanism of the p53 Isoform Δ40p53α in Regulating Collagen III Expression in TGFβ1-Induced LX-2 Human Hepatic Stellate Cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Novel Interleukin-6 Inducible Gene PDZ-Binding Kinase Promotes Tumor Growth of Multiple Myeloma Cells.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Akinobu OtaDepartment of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Haruhisa NakaoDivision of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan hnakao@aichi-med-u.ac.jp.ORCID 0000-0003-1794-0886
Yumi SawadaDivision of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Sivasundaram KarnanDepartment of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Md WahiduzzamanDepartment of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Tadahisa InoueDivision of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Yuji KobayashiDivision of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Takaya YamamotoDivision of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Norimitsu IshiiDivision of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Tomohiko OhashiDivision of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Yukiomi NakadeDivision of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Ken SatoDivision of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Kiyoaki ItohDivision of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Hiroyuki KonishiDepartment of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Yoshitaka HosokawaDepartment of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Masashi YonedaDivision of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Aichi Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Splice variants of certain genes impact on genetic biodiversity in mammals. The tumor suppressor TP53 gene (encoding p53) plays an important role in the regulation of tumorigenesis in hepatocellular carcinoma (HCC). Δ40p53α is a naturally occurring p53 isoform that lacks the N-terminal transactivation domain, yet little is known about the role of Δ40p53α in the development of HCC. Here, we first report on the role of Δ40p53α in HCC cell lines. In the TP53

Indexed as

Cellular SenescenceBase SequenceCarcinoma, HepatocellularCell ProliferationClone CellsG1 Phase Cell Cycle CheckpointsGene DeletionGene Knockdown TechniquesHep G2 CellsHumansLiver NeoplasmsModels, BiologicalMutant ProteinsPhenotypeTranscription, GeneticTumor Suppressor Protein p53Mutant ProteinsTumor Suppressor Protein p53Gene expressionGene targetingLiver cancerTumorigenesisΔ40p53

Identifiers

PMID27980070
PMCPMC5312733
OpenAlexW2581067091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.